Product Code: GDME1736EPD
GlobalData's Medical Devices sector report, "Tissue Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Tissue Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Tissue heart valve are a combination of tissue and synthetic biomaterials with the tissue itself being flexible. Bovine and porcine valves are included here.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Tissue Heart Valves under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Heart Valves under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Tissue Heart Valves Overview
3 Products under Development
- 3.1 Tissue Heart Valves - Pipeline Products by Stage of Development
- 3.2 Tissue Heart Valves - Pipeline Products by Segment
- 3.3 Tissue Heart Valves - Pipeline Products by Territory
- 3.4 Tissue Heart Valves - Pipeline Products by Regulatory Path
- 3.5 Tissue Heart Valves - Pipeline Products by Estimated Approval Date
- 3.6 Tissue Heart Valves - Ongoing Clinical Trials
4 Tissue Heart Valves - Pipeline Products under Development by Companies
- 4.1 Tissue Heart Valves Companies - Pipeline Products by Stage of Development
- 4.2 Tissue Heart Valves - Pipeline Products by Stage of Development
5 Tissue Heart Valves Companies and Product Overview
- 5.1 AGEless Biomedical Inc Company Overview
- 5.1.1 AGEless Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Anchorvalve Company Overview
- 5.2.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 Artivion Inc Company Overview
- 5.3.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 AutoTissue Berlin GmbH Company Overview
- 5.4.1 AutoTissue Berlin GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 Boston Children's Hospital Company Overview
- 5.5.1 Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 Colibri Heart Valve LLC Company Overview
- 5.6.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 Collplant Biotechnologies Ltd Company Overview
- 5.7.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 CorMatrix Cardiovascular Inc Company Overview
- 5.8.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 CroiValve Ltd Company Overview
- 5.9.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 Cytograft Tissue Engineering Inc (Inactive) Company Overview
- 5.10.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 Daidalos Solutions BV Company Overview
- 5.11.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 Edwards Lifesciences Corp Company Overview
- 5.12.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 enVVeno Medical Corp Company Overview
- 5.13.1 enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 Haimai Medical Technology Co Ltd Company Overview
- 5.14.1 Haimai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 Harvard Apparatus Regenerative Technology Inc Company Overview
- 5.15.1 Harvard Apparatus Regenerative Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.16 Medtronic Plc Company Overview
- 5.16.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
- 5.17 Meril Life Sciences Pvt Ltd Company Overview
- 5.17.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.18 National University of Singapore Company Overview
- 5.18.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
- 5.19 Neoolife Inc Company Overview
- 5.19.1 Neoolife Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.20 Revivicor Inc Company Overview
- 5.20.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.21 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
- 5.21.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
- 5.22 Stellenbosch University Company Overview
- 5.22.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
- 5.23 The Charles Stark Draper Laboratory Inc Company Overview
- 5.23.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.24 University of California Irvine Company Overview
- 5.24.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
- 5.25 University of Cambridge Company Overview
- 5.25.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
- 5.26 University of Zurich Company Overview
- 5.26.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview
- 5.27 ValveXchange, Inc. (Inactive) Company Overview
- 5.27.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.28 Venus Haoyue Medtech Ltd Company Overview
- 5.28.1 Venus Haoyue Medtech Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.29 Venus Medtech Hangzhou Inc Company Overview
- 5.29.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.30 Verigraft AB Company Overview
- 5.30.1 Verigraft AB Pipeline Products & Ongoing Clinical Trials Overview
- 5.31 VueKlar Cardiovascular Ltd (Inactive) Company Overview
- 5.31.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.32 W. L. Gore & Associates Inc Company Overview
- 5.32.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Tissue Heart Valves- Recent Developments
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer